Matinas biopharma to webcast conference call to discuss 2022 financial results and provide a business update on march 15, 2023

Bedminster, n.j., march 08, 2023 (globe newswire) -- matinas biopharma holdings, inc.  (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (lnc) platform technology, announces that it will report 2022 financial results after market close on wednesday, march 15, 2023. matinas management will host an investment community conference call and webcast to discuss financial results and provide a business update at 4:30 p.m. eastern time (1:30 p.m. pacific time).
MTNB Ratings Summary
MTNB Quant Ranking